American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,955 | -17,187 | -68,491 | 11,196 | 3,514 |
| Depreciation Amortization | 6,393 | 3,257 | 13,384 | 9,984 | 6,669 |
| Income taxes - deferred | 119 | 65 | -5,855 | -1,713 | -198 |
| Accounts receivable | 4,898 | 574 | 12,786 | 16,555 | 19,159 |
| Accounts payable and accrued liabilities | 623 | 1,300 | 4,124 | 3,623 | 1,322 |
| Other Working Capital | -3,660 | -9,564 | 12,186 | 1,309 | 1,289 |
| Other Operating Activity | 146 | 27 | 61,821 | -20,167 | -19,579 |
| Operating Cash Flow | $-34,438 | $-21,528 | $29,956 | $20,787 | $12,177 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,035 | -1,608 | -36,396 | -9,329 | -8,793 |
| Net Acquisitions | N/A | N/A | 615 | N/A | N/A |
| Purchase Of Investment | 18,279 | 16,540 | 5,160 | 66 | 23 |
| Purchase Sale Intangibles | -1 | -52 | N/A | N/A | N/A |
| Other Investing Activity | 15,777 | 10,735 | -41,327 | -30,354 | -26,902 |
| Investing Cash Flow | $26,021 | $25,667 | $-71,949 | $-39,617 | $-35,672 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,385 | N/A | 12,664 | N/A |
| Debt Issued | 7,322 | N/A | N/A | N/A | 5,798 |
| Debt Repayment | -306 | N/A | -3,160 | -2,750 | -4,801 |
| Common Stock Repurchased | -1,271 | -1,271 | -800 | -800 | -800 |
| Other Financing Activity | -3,822 | -1,942 | -302 | -7,157 | 0 |
| Financing Cash Flow | $1,924 | $173 | $-4,262 | $1,956 | $197 |
| Exchange Rate Effect | 1,495 | 363 | 4,314 | 5,323 | 3,760 |
| Beginning Cash Position | 52,628 | 52,628 | 94,569 | 94,569 | 94,569 |
| End Cash Position | 47,630 | 57,304 | 52,628 | 83,018 | 75,031 |
| Net Cash Flow | $-4,998 | $4,676 | $-41,941 | $-11,550 | $-19,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,438 | -21,528 | 29,956 | 20,787 | 12,177 |
| Capital Expenditure | -8,035 | -1,608 | -36,396 | -9,329 | -8,793 |
| Free Cash Flow | -42,472 | -23,136 | -6,440 | 11,459 | 3,384 |